Jim Simons
ONCY

Jim Simons’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History

Jim Simons’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-42,700
Closed -$21K – 3558
2015
Q2 		$21K Buy
+42,700
New +$29K ﹤0.01% 3187
2014
Q3 		– Sell
-36,000
Closed -$46K – 3118
2014
Q2 		$46K Buy
36,000
+12,400
+53% +$17.8K ﹤0.01% 2717
2014
Q1 		$43K Buy
23,600
+4,400
+23% +$7.43K ﹤0.01% 2763
2013
Q4 		$30K Sell
19,200
-12,300
-39% -$27.7K ﹤0.01% 2804
2013
Q3 		$76K Hold
31,500
– – ﹤0.01% 2716
2013
Q2 		$91K Buy
+31,500
New +$87.1K ﹤0.01% 2641

Other funds holding ONCY

VFS
VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NFG
Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 19.31% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Jim Simons's ONCY Position: Q3 2015 in Review

Jim Simons sold out of ONCOLYTICS BIOTECH INC (ONCY) in Q3 2015, closing a stake of 42,700 shares — an estimated $21K sold.

Jim Simons first reported a position in ONCY in Q2 2013 and held it in 6 quarters. The position peaked at $91K in Q2 2013. 27 funds tracked by Wall St. Rank hold ONCY as of Q3 2015.

  • Jim Simons reported no remaining ONCOLYTICS BIOTECH INC position as of Q3 2015 after selling out during the quarter.
  • Jim Simons sold 42,700 ONCOLYTICS BIOTECH INC shares in Q3 2015, an estimated $21K.
  • Jim Simons first reported a position in ONCOLYTICS BIOTECH INC in Q2 2013 and held it in 6 quarters.
  • Jim Simons's ONCOLYTICS BIOTECH INC position peaked at $91K in Q2 2013.
  • 27 funds tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q3 2015.

Based on Renaissance Technologies's 13F filing for Q3 2015, filed 12 Nov 2015.